These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 16690338

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The GH-IGF-I axis and the cardiovascular system: clinical implications.
    Colao A.
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cardiovascular disease and risk factors: the role of growth hormone.
    Isgaard J.
    Horm Res; 2004 Sep; 62 Suppl 4():31-8. PubMed ID: 15591764
    [Abstract] [Full Text] [Related]

  • 5. Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency.
    Colao A, di Somma C, Cuocolo A, Spinelli L, Tedesco N, Pivonello R, Bonaduce D, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 2001 May; 86(5):1874-81. PubMed ID: 11344175
    [Abstract] [Full Text] [Related]

  • 6. The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study.
    Colao A, di Somma C, Pivonello R, Cuocolo A, Spinelli L, Bonaduce D, Salvatore M, Lombardi G.
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1088-93. PubMed ID: 11889170
    [Abstract] [Full Text] [Related]

  • 7. Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency.
    Colao A, Di Somma C, Cuocolo A, Spinelli L, Acampa W, Spiezia S, Rota F, Savanelli MC, Lombardi G.
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5146-55. PubMed ID: 15985481
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Changes in endothelial dysfunction and associated cardiovascular disease morbidity markers in GH-IGF axis pathology.
    Graham MR, Evans P, Thomas NE, Davies B, Baker JS.
    Am J Cardiovasc Drugs; 2009 Sep; 9(6):371-81. PubMed ID: 19929035
    [Abstract] [Full Text] [Related]

  • 12. Long-term challenges in growth hormone treatment.
    Leal Cerro A.
    Horm Res; 2004 Sep; 62 Suppl 4():23-30. PubMed ID: 15591763
    [Abstract] [Full Text] [Related]

  • 13. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
    Cenci MC, Conceição FL, Soares DV, Spina LD, Brasil RR, Lobo PM, Michmacher E, Vaisman M.
    Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.
    Svensson J, Finer N, Bouloux P, Bevan J, Jonsson B, Mattsson AF, Lundberg M, Harris PE, Koltowska-Häggström M, Monson JP, KIMS International Board.
    Growth Horm IGF Res; 2007 Feb; 17(1):67-76. PubMed ID: 17223598
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic aspects of growth hormone and insulin-like growth factor-I treatment on visceral fat and insulin sensitivity in adults.
    Yuen KC, Dunger DB.
    Diabetes Obes Metab; 2007 Jan; 9(1):11-22. PubMed ID: 17199714
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S, Supornsilchai V, Aroonparkmongkol S, Srivuthana S.
    J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
    Saccà L, Napoli R, Cittadini A.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
    [Abstract] [Full Text] [Related]

  • 18. Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults.
    Oliveira JL, Aguiar-Oliveira MH, D'Oliveira A, Pereira RM, Oliveira CR, Farias CT, Barreto-Filho JA, Anjos-Andrade FD, Marques-Santos C, Nascimento-Junior AC, Alves EO, Oliveira FT, Campos VC, Ximenes R, Blackford A, Parmigiani G, Salvatori R.
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4664-70. PubMed ID: 17911170
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG.
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.